NCT07173465

Brief Summary

The current study aims to compare the effects of physical activity and Virtual Reality training on physical function, cognition and quality of life in patients with Schizophrenia. It is hypothesized in the literature that both physical activity and VR may have positive effects on the symptoms of PwS. Still, which modality may be more effective has yet to be discovered. By comparing the effects of physical activity and VR training on the symptoms of PwS, this study may provide valuable insights into the potential benefits of these interventions and inform the development of effective treatment strategies for PwS. Our study will discuss this relationship, and the results will be presented.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable schizophrenia

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

May 26, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 2, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 2, 2023

Completed
2.1 years until next milestone

First Posted

Study publicly available on registry

September 15, 2025

Completed
Last Updated

September 15, 2025

Status Verified

September 1, 2025

Enrollment Period

1 month

First QC Date

May 25, 2023

Last Update Submit

September 12, 2025

Conditions

Keywords

schizophreniaVirtual realityCognition

Outcome Measures

Primary Outcomes (8)

  • Simple Physical Activity Questionnaire

    The SIMPAQ is a five-point evaluation tool designed to assess physical activity and sedentary behavior in individuals with common mental disorders.

    12 weeks

  • Six minute walking test

    The 6-Minute Walk Test (6MWT) is a standardized physical performance test that measures the distance an individual can walk on a flat, hard surface in six minutes. It provides an objective assessment of functional exercise capacity, endurance, and overall mobility in daily life activities.

    12 weeks

  • The Mini-Mental State Examination

    The Mini-Mental State Examination (MMSE) is commonly used as a screening tool to assess cognitive function and detect cognitive impairments. While the MMSE is not specifically designed to evaluate cognitive deficits associated with schizophrenia, it can still provide some insights into general cognitive functioning in individuals with schizophrenia. In schizophrenia, cognitive impairments are frequently observed across various cognitive domains, including attention, working memory, executive function, verbal fluency, and processing speed. These cognitive deficits can significantly impact daily functioning, quality of life, and overall outcomes for individuals with schizophrenia.

    12 weeks

  • SF-36

    It is a widely used self-report questionnaire that assesses health-related quality of life (HRQoL)

    12 weeks

  • Berg Balance Scale

    Berg Balance Scale (BBS) is a standardized clinical test used to evaluate static and dynamic balance. It consists of 14 functional tasks, such as standing, reaching, and turning, each scored on a 5-point scale. The total score provides an objective measure of balance performance and fall risk in individuals.

    12 weeks

  • Time Up and Go Test

    The Timed Up and Go Test (TUG) is a standardized assessment that measures functional mobility. Participants are asked to stand up from a seated position, walk three meters, turn around, walk back, and sit down. The time taken to complete the task is recorded, providing an objective measure of mobility, balance, walking ability, and fall risk

    12 weeks

  • Sit to Stand test

    "The Sit-to-Stand Test is a functional performance measure used to assess lower limb strength, endurance, and mobility. Participants are asked to rise from a seated position to a full stand and return to sitting, repeated either for a set number of repetitions (e.g., five times) or within a fixed time period (e.g., 30 seconds). The total time or number of repetitions provides an objective indicator of lower body function and fall risk.

    12 weeks

  • Grip strength

    he Grip Strength Test is a standardized assessment of hand and forearm muscle strength. Participants are instructed to squeeze a calibrated hand dynamometer with maximum effort, usually in a seated position with the elbow at 90 degrees. The highest value from repeated trials is recorded, providing an objective measure of upper extremity strength and overall functional capacity

    12 weeks

Secondary Outcomes (3)

  • Calgary Depression Scale

    12 weeks

  • Katz Activities of Daily Living Scale

    12 weeks

  • Lawton Brody Instrumental Activities of Daily Living Scale

    12 weeks

Study Arms (3)

Physical Activity (PA group)

ACTIVE COMPARATOR

The program will be comprised of (5 minutes) Warm-up (5 minutes) Strengthening exercises (Lunges- squats) (10 minutes) Balance and Cardiovascular endurance (HIIT-penguin seesaw- table tilt) (15 minutes) Aerobic ex (stationary bike- dancing) (5 minutes) Cool down exercises and breathing control. In addition to all these, the individuals will continue occupational therapy.

Device: Virtual Reality (VR)

Virtual Reality (VR) group

ACTIVE COMPARATOR

Group 2 Virtual Reality (VR) group will undergo 45 minutes of the Nintendo Wii-FitTM game. First of all, it will start with games that include warm-up exercises ( 5 min) and then continue with games that include strengthening (5 min), balance (5 min) and aerobic exercises (15 min). Finally, the treatment will be terminated with games, including cool-down (5 min) exercises. In addition to all these, the individuals will continue occupational therapy.

Other: Physical Activity (PA group)

control group

SHAM COMPARATOR

This group will undergo regular occupational therapy at the treatment center

Other: occupational therapy

Interventions

Participants will engage in the VR gaming intervention three times a week for 12 weeks. Each session will last approximately 45 minutes, providing ample gameplay, instruction, and debriefing time.

Physical Activity (PA group)

The intervention includes a 5-minute warm-up, 10 minutes of strengthening exercises (lunges and squats), 20 minutes of balance and cardiovascular endurance activities (HIIT exercises), 20 minutes of aerobic exercises (stationary bike and dancing), and a 5-minute cool-down with breathing control. Participants also continue with personalized occupational therapy to enhance their functional abilities.

Virtual Reality (VR) group

the group will undergo their normal occupational therapy activities that include drawing, coloring, mathematical problems as well as solving mazes

control group

Eligibility Criteria

Age20 Years - 77 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between the ages of 20 and 77 years old.
  • Willing to participate in research.
  • Diagnosed with Schizophrenia according to the criteria defined in the DSM-IV by a psychiatrist.
  • Able to attend Community Mental Health Center regularly.
  • Not diagnosed with a mental disability, alcoholism, or drug addiction.
  • Scoring 40 points or higher on the GAF test, indicating a non-severe mental state.
  • Capable of fully understanding the purpose and content of the research.
  • Able to participate in physical activity that requires musculoskeletal movement without difficulty, as determined by self-report.

You may not qualify if:

  • Have significant cardiovascular, neuromuscular, endocrine, or other disorders that might prevent safe participation in the study.
  • Have a diagnosis of alcohol or substance abuse.
  • Have a secondary diagnosis of neurological disease or disease associated with the consumption of toxins, addiction to technology, or compulsive gambling.
  • Unable to read, understand, or respond to assessment tests.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kartal Dr Lutfi Kirdar City Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

SchizophreniaCognitive Dysfunction

Interventions

ExerciseOccupational Therapy

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersCognition DisordersNeurocognitive Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaRehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are assigned to one of two or more groups in parallel for the duration of the study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2023

First Posted

September 15, 2025

Study Start

May 26, 2023

Primary Completion

July 2, 2023

Study Completion

August 2, 2023

Last Updated

September 15, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations